Literature DB >> 11705494

Human papillomavirus genotypes in rural Mozambique.

X Castellsagué, C Menéndez, M P Loscertales, J R Kornegay, F dos Santos, F X Gómez-Olivé, B Lloveras, N Abarca, N Vaz, A Barreto, F X Bosch, P Alonso.   

Abstract

We studied the genotype distribution of cervical human papillomavirus (HPV) infections in an age-stratified sample of 262 women in Mozambique using the PGMYO9-PGMY11 primer system in a reverse line-blot strip-based assay with high sensitivity in type-specific amplification. Despite the low precision of the estimates, we found that HPV-16 was not the dominant type. Instead, HPV 35 was the most commonly identified genotype among HPV-positive women (16/96 [17%]) and women with cervical neoplasia (7/23 [30%]). Certain genotypes might have been under-detected in previous studies, and type-specific HPV distributions might vary across populations. Therefore, the estimated proportion of cervical neoplasia that could be prevented by an HPV-16-based vaccine could be lower than expected.

Entities:  

Mesh:

Year:  2001        PMID: 11705494     DOI: 10.1016/S0140-6736(01)06523-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  49 in total

1.  The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: implications for screen-and-treat strategies.

Authors:  Julia C Gage; Kayode O Ajenifuja; Nicolas A Wentzensen; Akinfolarin C Adepiti; Claire Eklund; Mary Reilly; Martha Hutchinson; Sholom Wacholder; Joe Harford; Amr S Soliman; Robert D Burk; Mark Schiffman
Journal:  Int J Cancer       Date:  2011-08-05       Impact factor: 7.396

Review 2.  Human papillomavirus in cervical cancer.

Authors:  F Xavier Bosch; Silvia de Sanjosé
Journal:  Curr Oncol Rep       Date:  2002-03       Impact factor: 5.075

3.  Comparison of hybrid capture II, linear array, and a bead-based multiplex genotyping assay for detection of human papillomavirus in women with negative pap test results and atypical squamous cells of undetermined significance.

Authors:  Manola Comar; Michelle R Iannacone; Giorgia Casalicchio; Sandrine McKay-Chopin; Massimo Tommasino; Tarik Gheit
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

4.  Prevalence and Risk Factors for Genital Human Papillomavirus Infections Among Women in Southwest Nigeria.

Authors:  Y T Nejo; D O Olaleye; G N Odaibo
Journal:  Arch Basic Appl Med       Date:  2018-05-04

5.  Cervical human papillomavirus infection in accra, ghana.

Authors:  Ab Domfeh; Ek Wiredu; Aa Adjei; Pfk Ayeh-Kumi; Tk Adiku; Y Tettey; Rk Gyasi; Hb Armah
Journal:  Ghana Med J       Date:  2008-06

6.  Epidemiology of HPV in HIV-positive and HIV-negative fertile women in Cameroon, West Africa.

Authors:  Andrew J Desruisseau; Delf Schmidt-Grimminger; Edith Welty
Journal:  Infect Dis Obstet Gynecol       Date:  2010-02-09

7.  High risk HPV types in southern Iranian patients with cervical cancer.

Authors:  S Farjadian; E Asadi; M Doroudchi; A Samsami Dehaghani; S Z Tabei; V P Kumar; A Ghaderi
Journal:  Pathol Oncol Res       Date:  2003-07-14       Impact factor: 3.201

8.  Genotype distribution of cervical human papillomavirus DNA in women with cervical lesions in Bioko, Equatorial Guinea.

Authors:  Benjamín García-Espinosa; Ma Paz Nieto-Bona; Sonsoles Rueda; Luís Fernando Silva-Sánchez; Ma Concepción Piernas-Morales; Patricia Carro-Campos; Luís Cortés-Lambea; Ernesto Moro-Rodríguez
Journal:  Diagn Pathol       Date:  2009-09-09       Impact factor: 2.644

9.  HPV infection in women with and without cervical cancer in Conakry, Guinea.

Authors:  N Keita; G M Clifford; M Koulibaly; K Douno; I Kabba; M Haba; B S Sylla; F J van Kemenade; P J F Snijders; C J L M Meijer; S Franceschi
Journal:  Br J Cancer       Date:  2009-06-16       Impact factor: 7.640

10.  Prevalence and type distribution of human papillomavirus in 5,000 British Columbia women--implications for vaccination.

Authors:  Richard A Moore; Gina Ogilvie; Daniel Fornika; Veronika Moravan; Marc Brisson; Mahsa Amirabbasi-Beik; Anita Kollar; Thomas Burgess; Ray Hsu; Laura Towers; Jane Lo; Jasenka Matisic; Angela Brooks-Wilson
Journal:  Cancer Causes Control       Date:  2009-05-29       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.